- Condition: Alzheimer's Disease
Interventions: Drug: E2609; Drug: Placebo
Sponsors: Eisai Inc.; Eisai Inc.
Not yet recruiting - verified May 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: saline; Drug: insulin detemir; Drug: Insulin
Sponsors: University of Washington; University of Washington; Alzheimer's Association
Recruiting - verified May 2012 - Condition: Alzheimer's Dementia
Intervention: Drug: ENA713
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Agitation; Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine); Drug: Placebo
Sponsors: Avanir Pharmaceuticals; Avanir Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Dementia; Alzheimer Disease
Intervention: Other: Neuroimaging
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention:
Sponsors: CHU de Reims; CHU de Reims
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Octohydroaminoacridine Succinate Tablets; Drug: Octohydroaminoacridine Succinate Tablets; Drug: Octohydroaminoacridine succinate Tablets; Drug: Placebo
Sponsors: Changchun Huayang High-tech Co., Ltd; Changchun Huayang High-tech Co., Ltd; Beijing Bionovo Medicine Development Co., Ltd.
Recruiting - verified May 2011 - Condition: Cognitive Impairment
Interventions: Behavioral: Active social engagement group; Behavioral: Control group
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Institute on Aging (NIA)
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Intervention: Other: Assessment of drive abilities
Sponsors: CHU de Reims; CHU de Reims
Not yet recruiting - verified March 2012 - Condition: Alzheimer Disease
Intervention: Other: CR1 impact
Sponsors: CHU de Reims; CHU de Reims
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: LY2886721; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Pamlab, L.L.C.; Pamlab, L.L.C.; Clionsky Neuro Systems, Inc.
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation
Sponsors: Ohio State University; Ali Rezai
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Biological: Albumin; Biological: Immune globulin
Sponsors: Grifols Biologicals Inc.; Instituto Grifols, S.A.; Grifols Biologicals Inc.
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Isotretinoin
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Other: Ophthalmological examination & Questionnaire
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Behavioral: assessment of memory; Biological: circulating tPA dosage; Genetic: ApoE4; Other: Brain imaging examination MRI and PET examinations
Sponsors: University Hospital, Caen; University Hospital, Caen; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: ABT-126; Drug: ABT-126; Drug: placebo
Sponsors: Abbott; Abbott
Recruiting - verified March 2012 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Interventions: Other: Physical Training and cognitive activity (EPC group); Other: Physical training (EP group); Other: control group
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified January 2012 - Conditions: Mild Cognitive Impairment; Mild Alzheimer's Disease
Interventions: Drug: AZD5213; Drug: AZD5213; Drug: AZD5213; Other: Placebo
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: TTP4000; Drug: Placebo
Sponsors: TransTech Pharma; TransTech Pharma
Recruiting - verified March 2012 - Conditions: Dementia; Alzheimer's Disease
Intervention: Other: PC-DATA tool
Sponsors: Queen's University; Queen's University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting - verified March 2012 - Conditions: Lewy Body Disease; Alzheimer's Disease
Intervention: Other: oculomotor measurements
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified January 2012 - Conditions: Alzheimer's Disease; Seizures
Intervention: Drug: Low/High/Placebo Dose Keppra (Levetiracetam)
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center
Recruiting - verified March 2012 - Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020; Drug: E2020
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified March 2012 - Condition: Dementia
Interventions: Behavioral: ESML-EX (Physical Activity Program); Behavioral: ESML-Social (Social Activity Program); Behavioral: Usual Care Control
Sponsors: University of Washington; University of Washington
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: MK-8931
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Caregivers of Persons With Dementia
Interventions: Behavioral: Sleep Behavioral Therapy A and NHMS; Behavioral: Sleep Behavioral Therapy B and NHMS
Sponsors: University of South Florida; University of South Florida; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Translational Research Informatics Center, Kobe, Hyogo, Japan; Translational Research Informatics Center, Kobe, Hyogo, Japan; Fudan University
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
Sponsors: Novartis; Novartis Pharmaceuticals; Ono Pharma
Not yet recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: Placebo Comparator; Drug: insulin detemir; Drug: insulin detemir
Sponsors: University of Washington; University of Washington; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution; Biological: Human albumin 0.25%
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation
Recruiting - verified May 2012 - Conditions: Moderate to Severe Alzheimer; Alzheimer Disease
Interventions: Drug: RPh201, botanical drug product; Drug: Placebo; Drug: RPh201, botanical extract product; Drug: Placebo
Sponsors: Regenera Pharma Ltd; Regenera Pharma Ltd; Kendle Toronto, Inc, a wholly-owned subsidiary of INC Research LLC
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Behavioral: Aerobic Exercise; Behavioral: Control Group
Sponsors: Federal University of Rio de Janeiro; Federal University of Rio de Janeiro; Rio de Janeiro State Research Supporting Foundation (FAPERJ); Conselho Nacional de Desenvolvimento Científico e Tecnológico
Recruiting - verified January 2012 - Condition: Mild Cognitive Impairment
Interventions: Drug: Atomoxetine; Drug: Placebo
Sponsors: Emory University; Emory University; National Institute on Aging (NIA)
Not yet recruiting - verified March 2012 - Condition: Amnestic Mild Cognitive Impairment
Intervention: Behavioral: cognitive intervention
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Resveratrol; Drug: Placebo
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Condition: Alzheimer's Disease
Interventions: Drug: BMS-241027; Drug: BMS-241027; Drug: BMS-241027; Drug: Placebo matching BMS-241027
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MK-8931; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Conditions: Alzheimer Disease; Battery
Interventions: Drug: Donepezil .; Drug: Placebo
Sponsors: University Hospital, Lille; University Hospital, Lille
Recruiting - verified October 2011 - Conditions: Alzheimer's Disease; Cognition Disorders
Intervention: Procedure: repetitive Transcranial Magnetic Stimulation (rTMS)
Sponsors: Centre Hospitalier Universitaire de Besancon; Pr Pierre Vandel; Neurology department of CHU Besancon (Dr Rumbach L, Dr Berger E, Dr Galmiche J); Memory Center of Research and Resources (MCRR) of Besancon (Dr Magnin E); Rapid-fr network (Dr Galmiche J); Clinical Investigation Centre - Technological Innovation (CIC-IT808); Funding by French Internal Project Call for Clinical Research(2010-A00659-30)
Recruiting - verified November 2011 - Conditions: Apathy; Alzheimer's Disease
Intervention: Procedure: Transcranial direct current stimulation
Sponsors: University of Sao Paulo; University of Sao Paulo
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: SAR228810; Drug: SAR228810
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Conditions: Alzheimer's Disease; Multiple Sclerosis; Parkinson's Disease; Huntington's Disease
Intervention: Other: blood samples
Sponsors: Sanguine Biosciences; Sanguine Biosciences
Recruiting - verified May 2012 - Conditions: Obstructive Sleep Apnea; Mild Cognitive Impairment
Intervention: Device: Continuous Positive Airway Pressure [CPAP]
Sponsors: George Mason University; George Mason University; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Conditions: Mild Alzheimer's Disease; Mild Cognitive Impairment
Interventions: Drug: HPP854; Drug: Placebo
Sponsors: High Point Pharmaceuticals, LLC.; High Point Pharmaceuticals, LLC.
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Galantamine
Sponsors: Janssen Pharmaceutical K.K.; Janssen Pharmaceutical K.K.
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: AZD3480
Sponsors: Targacept Inc.; Targacept Inc.
Recruiting - verified May 2012 - Condition: Alzheimers Disease
Interventions: Drug: Liraglutide; Drug: non-active study drug
Sponsors: University of Aarhus; University of Aarhus
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment; Vascular Dementia; Fronto-temporal Dementia; Primary Progressive Aphasia; Parkinson' Disease Dementia; Mixed Dementia
Intervention:
Sponsors: Exonhit; Exonhit
Recruiting - verified December 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Interventions: Drug: Minocycline; Drug: Sugar Pill
Sponsors: Huntington Medical Research Institutes; Huntington Medical Research Institutes
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Other: PET scan using florbetapir; Other: MRI Scan
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Conditions: Alzheimer's Disease; Schizophrenia
Interventions: Drug: amisulpride; Drug: amisulpride; Drug: amisulpride
Sponsors: Institute of Psychiatry, London; Institute of Psychiatry, London
Not yet recruiting - verified October 2011 - Conditions: Alzheimer Disease; Cognitive Impairment
Interventions: Drug: Sodium oligo-mannurarate 600mg; Drug: Sodium oligo-mannurarate 900mg; Drug: Placebo
Sponsors: Shanghai Greenvalley Pharmaceutical Co., Ltd.; Shanghai Greenvalley Pharmaceutical Co., Ltd.; Shanghai Mental Health Center
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS); Behavioral: NICE Cognitive Training
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; Neuronix Ltd
Recruiting - verified March 2012 - Conditions: Parkinson Disease; Alzheimer Disease
Intervention: Drug: [18F] CFPyPB
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified May 2012 - Conditions: Neurodegenerative Diseases; Memory Disturbances
Intervention:
Sponsors: Maastricht University Medical Center; Maastricht University Medical Center; Center for Translational Molecular Medicine; Leiden University Medical Center; Radboud University; VU University Medical Center
Recruiting - verified October 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Simvastatin + L-Arginine + Tetrahydrobiopterin
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Insulin glulisine; Drug: Placebo : Placebo Comparator
Sponsors: HealthPartners Research Foundation; HealthPartners Research Foundation
Recruiting - verified November 2011 - Conditions: Healthy; Alzheimer Disease
Interventions: Procedure: Standard CSR sampling procedure; Procedure: Alternate frequency CSR sampling procedure; Procedure: Standard frequent CSR sampling procedure with 800 mg ibuprofen; Procedure: Standard CSR sampling procedure
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Conditions: Alzheimer Disease; Depression
Intervention: Other: Eye movements will be recorded using video-oculography techniques based on both the corneal reflection principle and an infra-red light beam
Sponsors: Centre Hospitalier Universitaire de Besancon; Pr Pierre Vandel; Psychology laboratory of Besançon EA 3188; Centre Hospitalier Universitaire Dijon; Hospital of Novillars; funding by French Hospital Progeram of Clinical Research (PHRC 2009-A00942-55)
Recruiting - verified September 2011 - Condition: Alzheimer Disease
Intervention: Other: Hypnotherapy
Sponsors: Families To The Rescue; Families To The Rescue
Available - verified October 2011 - Condition: Mild Cognitive Impairment
Interventions: Behavioral: APOE genotype disclosure and Alzheimer's disease risk disclosure; Behavioral: Alzheimer's disease risk disclosure
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Human Genome Research Institute (NHGRI); University of Michigan; University of Pennsylvania; Howard University
Recruiting - verified September 2011 - Conditions: Mild Cognitive Impairment; Alzheimers Disease
Intervention:
Sponsors: Oslo University Hospital; Oslo University Hospital; South Eastern Area Health Service
Not yet recruiting - verified November 2011 - Condition: Mild Cognitive Impairment
Intervention:
Sponsors: Centre Hospitalier Esquirol; Centre Hospitalier Esquirol
Recruiting - verified February 2010 - Condition: Alzheimer's Disease
Interventions: Drug: rilapladib; Drug: placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: VI-1121; Drug: Placebo
Sponsors: VIVUS, Inc.; VIVUS, Inc.; Medpace, Inc.
Recruiting - verified April 2012 - Conditions: Alzheimer's Disease; Cardiovascular Risk Factors
Intervention: Other: optimal care of VRF
Sponsors: University Hospital, Lille; Florence PASQUIER; Assistance Publique - Hôpitaux de Paris; University Hospital, Rouen; Amiens University Hospital; University Hospital, Bordeaux; Centre Hospitalier Boulogne; Centre Hospitalier VALENCIENNES; Centre Hospitalier Lens; Centre Hospitalier Béthune; Centre Hospitalier Roubaix; Centre Hospitalier Saint-Philibert, GHICL; Hôpital des Bâteliers, Lille; Centre Hospitalier Calais; Centre Hospitalier Saint-Omer
Recruiting - verified October 2009 - Condition: Alzheimer Disease
Interventions: Behavioral: Web-based psycho-educational program; Behavioral: Consultation in memory clinic
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Direction de l’Hospitalisation et de l’Organisation des Soins (PREQHOS); Fondation Médéric Alzheimer
Not yet recruiting - verified August 2011 - Conditions: Personality Disorder; Depression; Neurodegeneration; Alzheimer's Disease; Epilepsy
Intervention: Device: EEG recording
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Not yet recruiting - verified August 2011 - Conditions: Mild Cognitive Impairment; Dementia
Interventions: Drug: ladostigil hemitartrate; Drug: Placebo
Sponsors: Avraham Pharmaceuticals Ltd; Avraham Pharmaceuticals Ltd
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Gulhane Military Medical Academy; Gulhane Military Medical Academy
Recruiting - verified August 2011 - Condition: MILD COGNITIVE IMPAIRMENT
Intervention: Procedure: Lumbar puncture
Sponsors: Qualissima; Qualissima; European Union
Recruiting - verified December 2011 - Condition: Alzheimer's Dementia
Interventions: Drug: Cilostazol; Drug: Placebo
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Korea OIAA
Recruiting - verified August 2011 - Condition: Alzheimer Disease
Interventions: Drug: Memantine; Drug: Vitamin D; Drug: Vitamin D placebo
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified March 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Sagramostim
Sponsors: University of South Florida; University of South Florida; The Dana Foundation
Recruiting - verified August 2011 - Conditions: Down Syndrome; Amyloid Deposition; Alzheimers Disease
Intervention:
Sponsors: University of Pittsburgh; University of Pittsburgh; University of Wisconsin, Madison
Recruiting - verified August 2011 - Condition: Alzheimer's Type Dementia
Interventions: Drug: E2020; Drug: Placebo
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment; Age-Related Memory Disorders
Intervention:
Sponsors: University of Arizona; University of Arizona; Banner Sun Health Research Institute; Barrow Neurological Institute; Mayo Clinic; National Institute on Aging (NIA); National Institutes of Health (NIH)
Recruiting - verified August 2011 - Conditions: Early Onset Alzheimer Disease; Alzheimer Disease; Obstructive Sleep Apnea Syndromes
Interventions: Device: CPAP Treatment; Device: No treatment
Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Centre Hospitalier Universitaire de Saint Etienne; Association Lyonnaise de Logistique Posthospitalière
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine; Drug: Rivastigmine
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Alzheimer Disease; Mild Cognitive Impairment; Neurodegenerative Diseases
Intervention: Drug: Florbetapir F 18
Sponsors: Avid Radiopharmaceuticals; Avid Radiopharmaceuticals
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified August 2011 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified July 2011 - Condition: Alzheimer's Disease
Intervention: Drug: R-pramipexole
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; University of Kansas; Alzheimer’s Drug Discovery Foundation
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: BIIB037; Other: Placebo
Sponsors: Biogen Idec; Biogen Idec
Recruiting - verified July 2011 - Condition: Disease Alzheimer
Interventions: Behavioral: Physical Therapy (standard); Behavioral: Balance and Gait training in Individualized sessions; Behavioral: Kinect; Behavioral: Group Xbox Kinect
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified June 2011 - Condition: Dementia in Nursing Home
Intervention: Other: MultiDisciplinary Team Meetings (MDTM)
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Intervention: Drug: rivastigmine patch
Sponsors: Dong-A University; Dong-A University; Novartis Korea Ltd.
Not yet recruiting - verified April 2011 - Conditions: Amyotrophic Lateral Sclerosis; Alzheimer Disease; Parkinson's Disease
Intervention:
Sponsors: China Medical University Hospital; China Medical University Hospital
Not yet recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: MSDC-0160; Drug: Placebo
Sponsors: Metabolic Solutions Development Company; Metabolic Solutions Development Company
Recruiting - verified November 2011 - Conditions: Alzheimer's Disease; Amyotrophic Lateral Sclerosis (ALS); Multiple Sclerosis (MS); Parkinson's Disease; Stroke; Traumatic Brain Injury
Intervention:
Sponsors: Avanir Pharmaceuticals; Avanir Pharmaceuticals
Recruiting - verified May 2011 - Condition: Alzheimer Disease
Intervention: Other: observational
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified May 2011 - Conditions: Dementia; Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Galantamine; Drug: Rivastigmine
Sponsors: Regenstrief Institute, IU Center for Aging Research; Regenstrief Institute, IU Center for Aging Research; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812)
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Carvedilol; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; Mount Sinai School of Medicine
Recruiting - verified March 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A; Drug: MABT5102A; Drug: placebo; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Conditions: Alzheimer Disease; Stroke; Parkinson's Disease; Lewy Body Dementia; Huntington Disease
Intervention: Behavioral: Computerized tests and Electrophysiological measurements
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified April 2011 - Conditions: Ischemic Stroke; Hemorrhagic Stroke
Intervention:
Sponsors: Ludwig-Maximilians - University of Munich; Ludwig-Maximilians - University of Munich
Recruiting - verified December 2011 - Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741; Drug: ORM-12741; Drug: Placebo for ORM-12741
Sponsors: Orion Corporation, Orion Pharma; Orion Corporation, Orion Pharma
Recruiting - verified February 2012 - Condition: Maximum Diagnostic Mass of [18Fluor]AZD4694
Interventions: Other: [18Fluor]AZD4694; Other: [18Fluor]AZD4694; Other: [18Fluor]AZD4694
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified August 2011 - Conditions: Alzheimer's Disease; Mild Cognitive Impairment
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2011 - Conditions: Alzheimer's Disease; Impaired Cognition; Memory Disorders
Intervention:
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified March 2011 - Condition: Alzheimer's Disease
Interventions: Behavioral: Home based occupational therapy; Behavioral: Best practices primary care
Sponsors: Regenstrief Institute, IU Center for Aging Research; Regenstrief Institute, IU Center for Aging Research; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Condition: Alzheimer's Disease
Interventions: Behavioral: Healthy Lifestyle Program; Behavioral: Physical Activity Intervention
Sponsors: Pennington Biomedical Research Center; Pennington Biomedical Research Center; Programs of All-Inclusive Care for the Elderly (PACE) of Baton Rouge
Recruiting - verified March 2011 - Condition: Alzheimer Disease
Intervention: Behavioral: questioning
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified December 2011 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Columbia University; Columbia University; National Institute on Aging (NIA)
Recruiting - verified August 2011 - Conditions: Stroke; Cognitive Disorders; Behavioral Disorders
Intervention: Behavioral: French adaptation of NINDS-CSN battery
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified February 2011 - Conditions: Dementia; Behavioral and Psychological Symptoms of Dementia
Interventions: Drug: Delta(9)-tetrahydrocannabinol (Delta-THC); Drug: Delta(9)-tetrahydrocannabinol; Drug: Placebo; Drug: Delta(9)-tetrahydrocannabinol (Delta-THC)
Sponsors: Radboud University; Radboud University
Recruiting - verified March 2012 - Condition: Alzheimer Disease
Interventions: Behavioral: Comprehensive, CBT-based, multi-component treatment; Behavioral: Treatment as usual
Sponsors: University of Zurich; University of Zurich; Psychiatric University Hospital, Zurich
Recruiting - verified October 2011 - Condition: Alzheimer Disease
Intervention: Drug: [18F]-FMH3
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Condition: Dementia Alzheimer's Type
Interventions: Drug: SAR110894D; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: Exendin-4 (Exenatide)
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Aging (NIA)
Recruiting - verified February 2010 - Condition: Alzheimer Disease
Interventions: Drug: Donepezil,; Drug: STA-1; Drug: placebo
Sponsors: Sinphar Pharmaceutical Co., Ltd; Sinphar Pharmaceutical Co., Ltd
Not yet recruiting - verified July 2011 - Condition: Alzheimer's Disease
Intervention: Drug: donepezil hydrochloride
Sponsors: Eisai Inc.; Eisai Co., Ltd.
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: SK-PC-B70M
Sponsors: SK Chemicals Co.,Ltd.; SK Chemicals Co.,Ltd.
Recruiting - verified November 2010 - Condition: Alzheimer Disease
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Recruiting - verified February 2012 - Conditions: Mild Cognitive Impairment (MCI); Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A; Drug: Placebo Comparator B; Drug: Active Comparator B; Drug: Placebo Comparator A
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Biological: ACC-001; Biological: ACC-001; Biological: ACC-001
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Interventions: Drug: gantenerumab; Drug: gantenerumab; Drug: placebo
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Late Onset Alzheimer Disease
Intervention: Drug: BAY 94-9172 (Florbetaben)
Sponsors: New York State Psychiatric Institute; Yaakov Stern; Bayer; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: E2212; Drug: placebo
Sponsors: Eisai Inc.; Eisai Inc.
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: caprylic triglyceride; Drug: long-chain triglyceride
Sponsors: Accera, Inc.; Accera, Inc.
Not yet recruiting - verified June 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease; Dementia With Lewy Bodies; Vascular Dementia
Intervention:
Sponsors: Skåne University Hospital; Skåne University Hospital; Lund University
Recruiting - verified September 2010 - Condition: Alzheimer Disease
Intervention: Drug: Drug: [18F] PBR111
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified January 2012 - Conditions: Cerebrovascular Disorders; Dementia
Intervention:
Sponsors: University Hospital, Lille; University Hospital, Lille; Ministry of Health, France
Recruiting - verified July 2010 - Condition: Alzheimer's Disease
Intervention: Other: 18F-PIB
Sponsors: University of Utah; University of Utah
Recruiting - verified September 2011 - Condition: Alzheimer's Dementia
Intervention: Device: Resonator
Sponsors: pico-tesla Magnetic Therapies, LLC; pico-tesla Magnetic Therapies, LLC
Recruiting - verified June 2011 - Conditions: Alzheimer's Disease; Capacity to Consent to Treatment; Capacity to Vote; Capacity to Design a Proxy
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified June 2010 - Condition: Alzheimer's Disease
Interventions: Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Drug: AAB-003 (PF-05236812); Other: Placebo
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Device: TMS, H coil
Sponsors: Brainsway; Brainsway
Recruiting - verified July 2011 - Conditions: Frontotemporal Dementia; Frontotemporal Degeneration; Alzheimer's Disease; Social Behavior
Intervention:
Sponsors: University of California, Los Angeles; University of California, Los Angeles; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Washington; University of Washington; Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System
Recruiting - verified March 2012 - Condition: Health Promotion
Interventions: Behavioral: Usual Care; Behavioral: Psycho-education; Behavioral: Psycho-education plus physical exercise
Sponsors: Emory University; Emory University; National Institute of Nursing Research (NINR)
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Intervention: Other: Alzhamyd
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified May 2010 - Condition: Alzheimer's Disease
Intervention: Drug: Solanezumab
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Interventions: Behavioral: Aerobic Exercise; Behavioral: Stretching
Sponsors: University of Kansas; University of Kansas
Recruiting - verified June 2011 - Condition: Alzheimer's Disease
Interventions: Drug: Prazosin; Drug: Placebo
Sponsors: Seattle Institute for Biomedical and Clinical Research; Seattle Institute for Biomedical and Clinical Research; National Institute on Aging (NIA); VA Puget Sound Health Care System
Recruiting - verified February 2012 - Condition: Alzheimer Disease
Interventions: Dietary Supplement: caprylidene; Dietary Supplement: Placebo
Sponsors: University of California, Los Angeles; University of California, Los Angeles; John Douglas French Foundation
Recruiting - verified October 2010 - Condition: Alzheimer's Disease
Interventions: Drug: Tamibarotene; Drug: Placebo
Sponsors: Osaka City University; Osaka City University
Recruiting - verified July 2011 - Condition: Alzheimer's Disease
Interventions: Biological: active: AFFITOPE AD02; Biological: control: Placebo
Sponsors: Affiris AG; Affiris AG
Recruiting - verified November 2011 - Condition: Alzheimer Disease
Interventions: Behavioral: Errorless Learning; Behavioral: Modeling; Behavioral: Trial and Error
Sponsors: Centre Hospitalier Universitaire de Nice; Department of Clinical Research and Innovation; Institut National de la Santé Et de la Recherche Médicale, France; Fondation Mederic Alzheimer
Recruiting - verified December 2011 - Conditions: Alzheimer's Disease; Posterior Cortical Atrophy; Logopenic Progressive Aphasia
Intervention:
Sponsors: Institut National de la Santé Et de la Recherche Médicale, France; Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified February 2012 - Conditions: Alzheimer Disease or Associated Disorder; Mild to Moderately Severe Dementia
Intervention: Other: Intervention of the social worker
Sponsors: Institut de Sante Publique, d'Epidemiologie et de Developpement; Institut de Sante Publique, d'Epidemiologie et de Developpement
Recruiting - verified July 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); Alzheimer's Disease Cooperative Study (ADCS); Northern California Institute for Research and Education (NCIRE); National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Donepezil; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Alzheimer's Disease; Amnestic Mild Cognitive Impairment
Intervention: Drug: Posiphen® tartrate capsules
Sponsors: QR Pharma Inc.; QR Pharma Inc.
Recruiting - verified June 2011 - Conditions: Mild Cognitive Impairment (MCI); Mild Alzheimer's Disease
Interventions: Other: auditory discrimination training; Other: physical movement training
Sponsors: University of Konstanz; University of Konstanz; University of Ulm
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Intervention: Drug: lipoic acid and fish oil concentrate
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified May 2012 - Condition: Apathy in Dementia
Interventions: Drug: Elontril; Drug: placebo
Sponsors: University Hospital, Bonn; University Hospital, Bonn; Center for Clinical Trials ZKS Cologne; Department of Psychiatry Charite Campus Benjamin Franklin Berlin; Department of Psychiatry Charite Campus Mitte Berlin; Universität Duisburg-Essen; Department of Psychiatry University of Erlangen; Center for Geriatric Psychiatry University of Freiburg; Department of Psychiatry University of Hamburg; University of Heidelberg; Central Institute for Mental Health Mannheim; Philipps University Marburg Medical Center; Ludwig-Maximilians - University of Munich
Recruiting - verified July 2010 - Condition: Mild Cognitive Impairment (MCI)
Interventions: Drug: Levetiracetam; Drug: Placebo; Drug: Placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA)
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Dementia
Intervention: Drug: donepezil
Sponsors: Samsung Medical Center; Samsung Medical Center; Eisai Korea Inc.
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Intervention: Drug: Bapineuzumab 0.5 mg/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Alzheimer Disease
Interventions: Drug: Bapineuzumab 0.5 mg/kg; Drug: Bapineuzumab 1.0 m/kg
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Disseminated Sclerosis
Intervention: Other: Cognitive impairment of multiple sclerosis
Sponsors: Nantes University Hospital; Nantes University Hospital
Recruiting - verified September 2009 - Condition: Alzheimer Disease
Intervention: Drug: ACC-001+ QS21
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Condition: Alzheimer Disease
Interventions: Drug: ACC-001+ QS21; Drug: ACC-001; Drug: ACC-001 + QS21
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Epigallocatechin-Gallate; Drug: Placebo
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified June 2011 - Condition: Memory Disorders
Intervention: Device: Deep brain stimulation
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Recruiting - verified July 2009 - Condition: Alzheimer's Disease
Intervention: Drug: memantine
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Alzheimer Disease
Intervention: Drug: bapineuzumab
Sponsors: Pfizer; Pfizer; JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Recruiting - verified March 2012 - Conditions: Alzheimer's Disease; Agitation
Interventions: Drug: citalopram; Drug: placebo
Sponsors: Johns Hopkins University; Johns Hopkins University; National Institute on Aging (NIA); National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Procedure: Bilateral chronic electrical stimulation of the hypothalamus/fornix
Sponsors: Centre Hospitalier Universitaire de Nice; Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified April 2009 - Conditions: Alzheimer Disease; Dementia
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; University of Alabama at Birmingham
Recruiting - verified February 2012 - Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF; Procedure: Placebo Surgery
Sponsors: Ceregene; Ceregene; Alzheimer's Disease Cooperative Study (ADCS)
Recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; National Institute on Aging (NIA)
Recruiting - verified October 2011 - Conditions: Parkinson Disease; Huntington Disease; Autistic Spectrum Disorders; Fragile X Syndrome; Alzheimer Disease; Mild Cognitive Impairment
Intervention: Drug: (18F)FPEB
Sponsors: Institute for Neurodegenerative Disorders; Institute for Neurodegenerative Disorders
Recruiting - verified February 2012 - Conditions: Alzheimer's Disease; Aphasia; Language Difficulties; Dementia
Intervention: Device: Repetitive Transcranial Magnetic Coil Stimulation (rTMS)
Sponsors: The New York Memory Services; The New York Memory Services
Recruiting - verified July 2011 - Conditions: Dementia; Alzheimer Disease; Dementia, Vascular; Sleep Disorders; Circadian Dysregulation
Interventions: Drug: Zolpidem CR; Drug: Zolpidem CR placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Device: 1Hz TMS with H2 coil; Device: 10Hz TMS with H2 coil to prefrontal and parieto-temporal cortex; Device: SHAM TMS with H2 coil
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center; Brainsway
Recruiting - verified September 2011 - Conditions: Mild Cognitive Impairment; Alzheimer's Disease; Traumatic Brain Injury
Interventions: Behavioral: explicit memory training; Behavioral: implicit memory training
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Emory University
Recruiting - verified May 2012 - Condition: Alzheimer Disease
Interventions: Drug: bapineuzumab; Drug: bapineuzumab; Drug: placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's disease
Sponsors: University Hospital, Strasbourg, France; University Hospital, Strasbourg, France
Recruiting - verified April 2012 - Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Centers for Medicare and Medicaid Services
Recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Forest Laboratories; DSM Nutritional Products, Inc.
Recruiting - verified April 2012 - Conditions: Alzheimer Disease; Late Onset Alzheimer Disease; Dementia
Intervention:
Sponsors: Indiana University; Indiana University; National Institute on Aging (NIA)
Recruiting - verified March 2012
 |
Join Clinical Trials for Alzheimer Disease |
